{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:07:42Z","timestamp":1777093662909,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Assisted injection is common among people who inject drugs (IDU), and has been associated with elevated risk for HIV infection and overdose. However, this practice has not been explored in the Asian context, including in Thailand, where HIV prevalence among IDU remains high.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Using multivariate logistic regression, we examined the prevalence and correlates of assisted injecting among IDU participating in the Mitsampan Community Research Project in Bangkok. We also sought to identify reasons for engaging in assisted injecting and those who provide this form of assistance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In total, 430 IDU participated in this study, including 376 (87.5%) who reported having ever required assistance injecting, and 81 (18.8%) who reported assisted injecting in the previous six months. In multivariate analyses, assisted injecting in the previous six months was independently and positively associated with being female (adjusted odds ratio [AOR]\u2009=\u20092.42; 95% confidence interval [CI]: 1.40 \u2013 4.18), being a weekly heroin injector (AOR\u2009=\u20091.78; 95% CI: 0.99 \u2013 3.20), syringe sharing (AOR\u2009=\u20092.08; 95% CI: 1.18 \u2013 3.68) and soft-tissue infection (AOR\u2009=\u20093.51; 95% CI: 1.43 \u2013 2.53). Having a longer injecting career (AOR\u2009=\u20090.96; 95% CI: 0.94 \u2013 0.99) was negatively associated with assisted injecting. Primary reasons given for engaging in assisted injecting included being new to injecting and lacking knowledge on how to inject. The most common providers of assistance with injecting were close friends.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>We found a high prevalence of assisted injecting among IDU in Bangkok, with females, frequent heroin injectors, those with shorter injecting careers being more likely to engage in this practice. Those who require help with the injecting process are more likely to share syringes, and have skin infections. These findings indicate the need for interventions focused on promoting safer and self-administered injections.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1747-597x-8-32","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T06:28:06Z","timestamp":1378880886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Assisted injection among people who inject drugs in Thailand"],"prefix":"10.1186","volume":"8","author":[{"given":"William K","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianping","family":"Ti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanna","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karyn","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paisan","family":"Suwannawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,9,10]]},"reference":[{"key":"266_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1097\/00002030-199410000-00011","volume":"8","author":"D Kitayaporn","year":"1994","unstructured":"Kitayaporn D, Uneklabh C, Weniger BG, Lohsomboon P, Kaewkungwal J, Morgan WM, Uneklabh T: HIV-1 incidence determined retrospectively among drug users in Bangkok. Thailand. AIDS. 1994, 8: 1443-1450.","journal-title":"Thailand. AIDS"},{"key":"266_CR2","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/S0140-6736(00)04562-1","volume":"357","author":"AH Kral","year":"2001","unstructured":"Kral AH, Bluthenthal RN, Lorvick J, Gee L, Bacchetti P, Edlin BR: Sexual transmission of HIV-1 among injection drug users in San Francisco USA: risk-factor analysis. Lancet. 2001, 357: 1397-1401. 10.1016\/S0140-6736(00)04562-1.","journal-title":"Lancet"},{"key":"266_CR3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF03405004","volume":"93","author":"LA Jackson","year":"2002","unstructured":"Jackson LA, Bailey DL, Fraser JR: Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia. An exploratory look at community and interpersonal influences. Can J Public Health. 2002, 93: 219-222.","journal-title":"Can J Public Health"},{"key":"266_CR4","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1046\/j.1360-0443.1999.9456755.x","volume":"94","author":"AH Kral","year":"1999","unstructured":"Kral AH, Bluthenthal RN, Erringer EA: Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction. 1999, 94: 675-683. 10.1046\/j.1360-0443.1999.9456755.x.","journal-title":"Addiction"},{"key":"266_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/jurban\/jtg137","volume":"80","author":"JL Evans","year":"2003","unstructured":"Evans JL, Hahn JA, Page-Shafer K: Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). J Urban Health. 2003, 80: 137-146. 10.1093\/jurban\/jtg137.","journal-title":"J Urban Health"},{"key":"266_CR6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF03403560","volume":"94","author":"E Wood","year":"2003","unstructured":"Wood E, Spittal PM, Kerr T, Small W, Tyndall MW, O\u2019Shaughnessy MV, Schechter MT: Requiring help injecting as a risk factor for HIV infection in the Vancouver epidemic: Implications for HIV prevention. Can J Public Health. 2003, 94: 355-359.","journal-title":"Can J Public Health"},{"key":"266_CR7","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/00002030-200204120-00021","volume":"16","author":"E Wood","year":"2002","unstructured":"Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, Montaner JS, O\u2019Shaughnessy MV, Schechter MT: Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS. 2002, 16: 941-943. 10.1097\/00002030-200204120-00021.","journal-title":"AIDS"},{"key":"266_CR8","first-page":"405","volume":"165","author":"E Wood","year":"2001","unstructured":"Wood E, Tyndall MW, SPittal PM, Hoggs RS, Kerr T, Li K: Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Can Med Assoc J. 2001, 165: 405-410.","journal-title":"Can Med Assoc J"},{"key":"266_CR9","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0733-8619(18)30141-5","volume":"11","author":"RM Richter","year":"1993","unstructured":"Richter RM: Infections other than AIDS. Neurol Clin. 1993, 11: 591-603.","journal-title":"Neurol Clin"},{"key":"266_CR10","first-page":"83","volume":"40","author":"JM O\u2019Connell","year":"2005","unstructured":"O\u2019Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, Wood E: Requiring help injecting independently predicts incident HIV infection among injection drug users. Epidemiology and Social Science. 2005, 40: 83-88.","journal-title":"Epidemiology and Social Science"},{"key":"266_CR11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/00002030-200102160-00013","volume":"15","author":"S Vanichseni","year":"2001","unstructured":"Vanichseni S, Kitayaporn D, Mastro TD, Mock PH, Raktham S, Des Jarlais DC, Sujarita S, Srisuwanvilai L, Young NL, Wasi C, Subbarao S, Heyward WL, Esparza J, Choonpanya K: Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS. 2001, 15: 397-405. 10.1097\/00002030-200102160-00013.","journal-title":"AIDS"},{"key":"266_CR12","first-page":"894","volume":"166","author":"PM Spittal","year":"2002","unstructured":"Spittal PM, Craib KJ, Wood E: Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002, 166: 894-899.","journal-title":"Can Med Assoc J"},{"key":"266_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1080\/09540120050123909","volume":"12","author":"R MacRae","year":"2000","unstructured":"MacRae R, Aalto E: Gendered power dynamics and HIV risk in drug-usingsexual relationships. AIDS Care: Psychological and Socio-medical Aspects of AIDS\/HIV. 2000, 12: 505-516.","journal-title":"AIDS Care: Psychological and Socio-medical Aspects of AIDS\/HIV"},{"key":"266_CR14","first-page":"802","volume":"164","author":"PM Spittal","year":"2001","unstructured":"Spittal PM, Schechter MT: Injection drug use and despair through the lens of gender. Can Med Assoc J. 2001, 164: 802-803.","journal-title":"Can Med Assoc J"},{"key":"266_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-7-20","volume":"7","author":"N Fairbairn","year":"2010","unstructured":"Fairbairn N, Small W, Van Borek N, Wood E, Kerr T: Social structural factors that shape assisted injecting practices among injection drug users in Vancouver, Canada: a qualitative study. Harm Reduction Journal. 2010, 7: 1-7. 10.1186\/1477-7517-7-1.","journal-title":"Harm Reduction Journal"},{"key":"266_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","volume":"17","author":"MW Tyndall","year":"2003","unstructured":"Tyndall MW, Currie S, Spittal P: Intensive injection cocaine use as the Primary risk factor in the Vancouver HIV-1 epidemic. AIDS. 2003, 17: 887-893. 10.1097\/00002030-200304110-00014.","journal-title":"AIDS"},{"key":"266_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1747-597X-4-16","volume":"4","author":"D Werb","year":"2009","unstructured":"Werb D, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Lai C, Kerr T: Drug use patterns among Thai illicit drug injectors amidst increased police presence. Subst Abuse Treat Prev Policy. 2009, 4: 16-10.1186\/1747-597X-4-16.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"266_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1360-0443.2003.00236.x","volume":"98","author":"L Francesco","year":"2003","unstructured":"Francesco L, Bruneau J, Stewart J: Understanding polydrug use: review of heroin and cocaine co-use. Addiction. 2003, 98: 7-22. 10.1046\/j.1360-0443.2003.00236.x.","journal-title":"Addiction"},{"key":"266_CR19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S1473-3099(04)01006-0","volume":"4","author":"E Wood","year":"2004","unstructured":"Wood E, Kerr T, Montaner JS: Rationale for evaluating North America\u2019s first medically supervised safer injecting facility. Lancet Infect Dis. 2004, 4: 301-306. 10.1016\/S1473-3099(04)01006-0.","journal-title":"Lancet Infect Dis"},{"key":"266_CR20","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1080\/713659379","volume":"19","author":"K Dolan","year":"2000","unstructured":"Dolan K, Kimber J, Fry C, Fitzgerald J, McDonald D, Frautmann F: Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev. 2000, 19: 337-346. 10.1080\/713659379.","journal-title":"Drug Alcohol Rev"},{"key":"266_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0955-3959(98)00072-3","volume":"10","author":"W de Jong","year":"1999","unstructured":"de Jong W, Weber U: The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany and Switzerland. International Journal of Drug Policy. 1999, 10: 99-108. 10.1016\/S0955-3959(98)00072-3.","journal-title":"International Journal of Drug Policy"},{"key":"266_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF01318589","volume":"41","author":"C Ronco","year":"1996","unstructured":"Ronco C, Spuhler G, Coda P, Schopfer R: Evaluation for alley-rooms I, II, and III in Basel. Social and Preventative Medicine. 1996, 41: 58-68.","journal-title":"Social and Preventative Medicine"},{"key":"266_CR23","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1467-842X.2000.tb00507.x","volume":"24","author":"I van Beck","year":"2000","unstructured":"van Beck I, Gilmour S: Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Australia and New Zealand Journal of Public Health. 2000, 24: 540-542. 10.1111\/j.1467-842X.2000.tb00507.x.","journal-title":"Australia and New Zealand Journal of Public Health"},{"key":"266_CR24","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1177\/1049732311400919","volume":"21","author":"W Small","year":"2011","unstructured":"Small W, Shoveller J, Moore D, Tyndall M, Wood E, Kerr T: Injection drug user\u2019s access to a supervised injection facility in Vancouver, Canada: The influence of operating policies and local drug culture. Qual Health Res. 2011, 21: 743-756. 10.1177\/1049732311400919.","journal-title":"Qual Health Res"},{"key":"266_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.drugpo.2006.12.008","volume":"18","author":"T Kerr","year":"2007","unstructured":"Kerr T, Small W, Moore D, Wood E: A micro-environmental intervention to reduce the harms associated with drug-related overdose: Evidence from the evaluation of Vancouver\u2019s safer injection facility. International Journal of Drug Policy. 2007, 18: 37-45. 10.1016\/j.drugpo.2006.12.008.","journal-title":"International Journal of Drug Policy"},{"key":"266_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/00126334-200301010-00002","volume":"32","author":"E Wood","year":"2003","unstructured":"Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW: The potential public health and community impacts of safer injecting facilities: Evidence from a cohort of injection drug users. J Acquir Immune Defic Syndr. 2003, 32: 2-8. 10.1097\/00126334-200301010-00002.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"266_CR27","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/002204260203200113","volume":"32","author":"RS Broadhead","year":"2002","unstructured":"Broadhead RS, Kerr TH, Grund JP, Altice FL: Safer injection facilities in North America: Their place in public policy and health initiatives. J Drug Issues. 2002, 32: 329-355. 10.1177\/002204260203200113.","journal-title":"J Drug Issues"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1747-597X-8-32.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T01:26:41Z","timestamp":1630546001000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/1747-597X-8-32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["266"],"URL":"https:\/\/doi.org\/10.1186\/1747-597x-8-32","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,10]]},"assertion":[{"value":"7 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"32"}}